Riddhi Siddhi Gluco Biols Receives Mixed Verdict from Securities Appellate Tribunal on SEBI Appeals

2 min read     Updated on 11 Mar 2026, 04:30 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Riddhi Siddhi Gluco Biols Limited received a mixed verdict from the Securities Appellate Tribunal on its appeals against SEBI orders. While one appeal was dismissed, the other was partly allowed with reduced debarment periods. The company must achieve MPS compliance within 5 months, with varying debarment periods imposed on the company and associated entities ranging from 6 months to compliance-linked durations.

34772431

*this image is generated using AI for illustrative purposes only.

Riddhi Siddhi Gluco Biols Limited has disclosed receiving a Securities Appellate Tribunal (SAT) order dated March 09, 2026, which provides a mixed outcome on the company's appeals against SEBI orders. The company received the order on March 10, 2026, addressing two separate appeals challenging previous SEBI decisions.

SAT Appeal Outcomes

The tribunal delivered contrasting verdicts on the two appeals filed by the company and its promoters:

Appeal Details: Outcome
Appeal No. 543 of 2021 (against SEBI AO order dated July 02, 2021): Dismissed
Appeal No. 588 of 2021 (against SEBI WTM order dated August 11, 2021): Partly allowed with modified debarment period
MPS Non-compliance Findings: Upheld by SAT

Debarment and Compliance Directives

The SAT has imposed specific debarment periods and compliance requirements on various entities and individuals associated with the company:

Entity/Individual: Debarment Period
Riddhi Siddhi Gluco Biols Limited: Until MPS compliance + 6 months thereafter
Mr. Ganpatraj Chowdhary: Until MPS compliance + 6 months thereafter
Mr. Siddharth Chowdhary: Until MPS compliance + 6 months thereafter
Creelotex Engineers Private Limited: 6 months from SAT order date
Ganpatraj Chowdhary HUF: 6 months from SAT order date
Mr. Mukesh Samdaria (CFO): 6 months from SAT order date

Minimum Public Shareholding Compliance

The tribunal has directed the company to comply with Minimum Public Shareholding requirements within 5 months from the order date. The SAT upheld SEBI's findings regarding the company's non-compliance with MPS norms, which formed part of the original violations. The company faces allegations related to delisting under various Securities Laws in addition to the MPS requirement violations.

Financial Impact and Previous Penalties

The company has indicated that the SAT order will have no quantifiable monetary impact on its financial or operational activities. However, a penalty of Rs. 5 lakh each imposed on the company and two promoter directors by the Adjudicating Officer's order dated July 02, 2021, was already deposited with SEBI following earlier SAT directions dated August 12, 2021.

Company's Response

Riddhi Siddhi Gluco Biols Limited has stated that it is legally examining the contents of the SAT order and will take appropriate legal actions as advised. The disclosure was made under Regulation 30 of the SEBI Listing Regulations, with the company secretary Sharad Jain signing the compliance document on March 11, 2026.

Historical Stock Returns for Riddhi Siddhi Gluco Biols

1 Day5 Days1 Month6 Months1 Year5 Years
-4.65%-1.80%-10.77%-17.47%-10.57%+76.04%
Riddhi Siddhi Gluco Biols
View Company Insights
View All News
like20
dislike

Riddhi Siddhi Gluco Biols Announces Q3FY26 Results with 66.73% Profit Decline

2 min read     Updated on 07 Feb 2026, 03:40 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Riddhi Siddhi Gluco Biols Limited officially announced Q3FY26 financial results with standalone net profit declining 66.73% to ₹886.05 lakhs from ₹2,662.85 lakhs YoY, while revenue remained relatively stable at ₹3,123.92 lakhs. The company's consolidated results showed net loss of ₹128.62 lakhs due to losses from discontinued paper division operations, though continuing operations generated profit of ₹39.30 lakhs.

32004650

*this image is generated using AI for illustrative purposes only.

Riddhi Siddhi Gluco Biols Limited officially announced its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The company's Board of Directors approved the results at a meeting held on February 7, 2026, along with limited review reports from statutory auditors Batliboi & Purohit, Chartered Accountants.

Standalone Financial Performance

The company's standalone performance for Q3FY26 showed mixed results with significant profitability challenges. While revenue remained relatively stable, the bottom line was severely impacted.

Metric: Q3FY26 Q3FY25 Change (%)
Revenue from Operations: ₹3,123.92 lakhs ₹3,189.66 lakhs -2.06%
Other Income: ₹2,231.97 lakhs ₹2,840.21 lakhs -21.42%
Total Income: ₹5,355.89 lakhs ₹6,029.87 lakhs -11.18%
Net Profit After Tax: ₹886.05 lakhs ₹2,662.85 lakhs -66.73%
Earnings Per Share: ₹12.43 ₹37.35 -66.73%

For the nine months ended December 31, 2025, the company reported revenue from operations of ₹20,194.52 lakhs compared to ₹7,468.59 lakhs in the corresponding period of FY25. Net profit for nine months FY26 stood at ₹5,112.98 lakhs against ₹8,413.52 lakhs in nine months FY25.

Segment-wise Performance Analysis

The company operates primarily in two business segments with varying performance trajectories across different verticals.

Segment: Q3FY26 Revenue Q3FY25 Revenue Nine Months FY26 Nine Months FY25
Wind Energy Generation: ₹81.02 lakhs ₹67.44 lakhs ₹1,306.25 lakhs ₹1,061.07 lakhs
Trading Business: ₹3,042.90 lakhs ₹3,122.22 lakhs ₹18,888.27 lakhs ₹6,407.52 lakhs

The wind energy generation segment demonstrated consistent growth in both quarterly and nine-month periods, while the trading business segment experienced a marginal quarterly decline but substantial nine-month growth.

Consolidated Financial Results

The consolidated performance includes the parent company and its subsidiary Shree Rama Newsprint Limited, with results significantly impacted by discontinued operations.

Parameter: Q3FY26 Q3FY25 Nine Months FY26 Nine Months FY25
Revenue from Continuing Operations: ₹4,008.20 lakhs ₹4,432.70 lakhs ₹22,679.28 lakhs ₹10,749.17 lakhs
Profit from Continuing Operations: ₹39.30 lakhs ₹1,904.44 lakhs ₹2,532.99 lakhs ₹6,039.86 lakhs
Loss from Discontinued Operations: ₹(167.92) lakhs ₹(7,306.16) lakhs ₹(482.32) lakhs ₹(7,719.57) lakhs
Net Profit/(Loss): ₹(128.62) lakhs ₹(5,401.72) lakhs ₹2,050.67 lakhs ₹(1,679.71) lakhs

Regulatory and Legal Matters

The company continues to face ongoing regulatory proceedings with income tax authorities. An appeal has been filed with the Income Tax Appellate Tribunal, Ahmedabad regarding additions of ₹308 lakhs made by the Assessing Officer for assessment years 2013-14 to 2020-21, which the company considers as contingent liability.

Additionally, two matters remain pending before the Securities Appellate Tribunal related to SEBI orders, including a penalty of ₹5 lakhs each on the company and two promoter directors, and compliance requirements for Minimum Public Shareholding. Both matters were heard by SAT on December 16, 2025, with orders reserved.

Financial Position and Outlook

The company maintains total assets of ₹1,99,770.73 lakhs as of December 31, 2025, compared to ₹1,87,737.51 lakhs in the previous year. The paid-up equity share capital remains unchanged at ₹712.97 lakhs with a face value of ₹10 per share. The subsidiary's paper division continues as discontinued operations with piecemeal asset disposal ongoing.

Historical Stock Returns for Riddhi Siddhi Gluco Biols

1 Day5 Days1 Month6 Months1 Year5 Years
-4.65%-1.80%-10.77%-17.47%-10.57%+76.04%
Riddhi Siddhi Gluco Biols
View Company Insights
View All News
like17
dislike

More News on Riddhi Siddhi Gluco Biols

1 Year Returns:-10.57%